Archive for the ‘research’ Category

Revisiting Incarnation Children’s Center – AIDS Drug Trials Funded by Fauci

https://www.omsj.org/blogs/incarnation-childrens-center-aids-trials

Revisiting Incarnation Children’s Center – AIDS Drug Trials

February 23, 2014

(LIAM SCHEFF) –  In 2004, I broke open the NIH Clinical Trial Scandal, the internationally-covered story of hundreds of New York City orphans used by government agencies and pharmaceutical companies in deadly AIDS drug trials.

In reporting this issue, I entered the orphanage where children were being used as guinea pigs, and over a period of several years, took interviews with mothers, children and childcare workers at the Incarnation Children’s Center. I also interviewed the medical director, and investigated the FDA documentation and published medical literature on the tests and drugs used, drugs which were often force-fed through nasal and gastric tubes to the children. I reported several deaths in children, and although the mainstream denied that any deaths were due to drug toxicity, they admit that over 200 children died.

(See link for article)

_____________________

**Comment**

Your tax dollars at work, directed by Dr. Fauci, head of the National Institute of Allergy and Infectious Diseases (NIAID) since 1984 – and current Hollywood star for COVID propaganda.  Please take the time to listen to 10 full minutes of COVID contradictory propaganda from our leaders, including Fauci.

Summary:

  • NYC hired Vera Institute to create a final report on this inhumane experiment but weren’t given access to the children’s medical records. The VERA investigator refused to take data from Scheff that listed the trials, drugs used, and recorded ‘black box’ warnings.
  • The report stated that out of 532 children in the study, 25 died directly during the study, another 55 died later in foster care, and the Director at VERA as of 2009 stated that 29% of the remaining 417 had died. In a follow-up interview, the head of VERA admitted that many more children had died.
  • According to this: one staff member, Jacklyn Hoerger, spoke out about the deceitful protocol:
    • “We were told that if they were vomiting, if they lost their ability to walk, if they were having diarrhea, if they were dying, then all of this was because of their HIV infection. I just faithfully gave it as I was told by doctors.” Fauci and the NIAID claimed the drugs and vaccines were the only chance for survive.  (Sound familiar?)
    • Hoerger put that theory to the test and adopted two half-sisters. She removed the children from the experiments and watched them recover. The girls began eating properly for the first time in their lives and improved “almost instantaneously.” Hoerger concluded that the drugs were causing the children’s bodies to shut down. When the doctors and administrators found out she was ostracized as a “negligent parent.” The girls were taken from her and she wasn’t allowed to see them again.
    • Fauci wanted adherence at all costs – even the children’s well being.  No matter what happened, doctors could blame HIV; however, NIAID and their partners presumed all the children had HIV.  They never used any laboratory confirmation.  (I will add that PCR testing for HIV is just as abysmal as it is for COVID and should never be trusted by itself for diagnosis)
    • What isn’t discussed is the fact that when parents withdrew consent, their child was removed and placed in a foster home that would comply. 
  • Watch the documentary “Guinea Pig Kids”, and read Celia Farber and the late Liam Scheff’s expose’ on these crimes against humanity, which also a WBAI New York news-report
  • Both Wikipedia and the NY Times covered up the sordid details and heralded it as one of the great successes of AIDS treatment. They erroneously state that doctors obtained permission for using the foster kids, but admits that the “permissions” for many of these children are “missing,” (or were never there).  They also didn’t review the children’s medical files – but still conclude it was a medical success.
  • Fauci got away with crime, and appears to be getting away with the current crimes against humanity regarding COVID.  He’s known by many as “the Teflon man” as nothing sticks to him.

Category:

Activism, research, Treatment

Physician Frustration With Lyme Disease Patients

https://danielcameronmd.com/physician-frustration-with-lyme-disease-patients/

Physician frustration with Lyme disease patients

physician-frustration-lyme-disease-patients

In their study, “Primary care clinical provider knowledge and experiences in the diagnosis and treatment of tick‑borne illness: a qualitative assessment from a Lyme disease endemic community,” Mattoon and colleagues examined frontline and primary care doctor’s knowledge and practices for identifying patients with tick-borne diseases.

By

They found that some physicians are frustrated with Lyme disease (LD) patients. “Providers described challenges and frustrations in counseling patients with strong preconceptions of LD diagnosis and treatment in the context of chronic infection,” the authors wrote.

The authors came to this conclusion after a series of focus groups with 14 clinicians from three primary care practices and a survey of 24 urgent and emergency care clinicians.

The diagnostic process contributed to some of the frustration.

“Clinicians had a self-professed lack of awareness of TBDs [tick-borne diseases] outside of Lyme disease, noting that they were unfamiliar with the signs, symptoms, and appropriate serologic testing needed to diagnose non-Lyme TBDs, as well as the prevalence of these TBDs in their local communities.”

More specifically, nearly 50% of clinicians reported feeling “not at all knowledgeable on anaplasmosis.”

Treatment approaches also led to frustration. Clinicians:

“appeared to have difficulty in identifying the appropriate treatment approach for patients with nonspecific symptoms and negative Lyme disease serology, with only 66.7% [of clinicians] providing the correct answer,” the authors wrote.

Problems presented by patients with chronic illness

Some doctors were frustrated when patients challenged their treatment plan.  “This commonly came in the form of patients rejecting results of serologic testing, wanting a different length of antibiotic course than that prescribed, or seeking an alternative treatment modality.”

Some doctors were frustrated with the time and effort involved in taking care of these patients.

“Clinical encounters with these patients were described as time consuming and difficult.”

Finally, some doctors were frustrated by contradictory information by outside providers. “Two focus group discussions centered around differences in care plans between participants’ primary care offices and what they termed the ‘Lyme literate’ community.”

Need for more education and training

Clinicians felt additional training would be help avoid some of these problems. The authors cited an example:

“I ordered what I thought was sort of the standard Lyme titer. It came back negative and this kid continued to have a swollen knee…He went to the orthopedist. They couldn’t figure it out. He’s going up to the rheumatologist. And it’s just because I ordered the wrong test…I think [I] ordered the PCR, which was like, you know, the quick and easy one. But actually that wasn’t probably a good one to do.” [FG3, Pediatrics]

“The gaps in knowledge identified through the focus group and online survey data, coupled with the consistent necessity to provide point-of-care counseling and education to patients,” the authors concluded, “highlight a pressing need for resources and support for primary care and frontline providers treating patients for TBDs.”

Editor’s perspective

Neither the authors nor the participating clinicians questioned the accuracy of the diagnostic testing and treatment plans they administer.
Related Articles:

Lyme disease skin rash puzzles doctors, leads to misdiagnosis
Doctors reluctant to diagnose Lyme disease?
Lyme disease myths lead to frustrations for doctors

References:
  1. Mattoon, S., Baumhart, C., Barsallo Cochez, A.C. et al. Primary care clinical provider knowledge and experiences in the diagnosis and treatment of tick-borne illness: a qualitative assessment from a Lyme disease endemic community. BMC Infect Dis 21, 894 (2021). https://doi.org/10.1186/s12879-021-06622-6

_____________________

**Comment**

A cringe-worthy article for sure.  I couldn’t help but think that if doctors think they are frustrated, try being a severely sick patient, perhaps who’s spouse is just as ill, whose life is spiraling down a vortex of doom in every way possible and your doctor, the person who is supposed to have the answers, is completely and hopelessly in the dark.

Talk about frustration!

My advice: bypass these doctors at all costs and get straight to an educated, Lyme literate doctor with experience.  It will save you time, money, and heartache in the end.

Category:

Lyme, research

Could An 80-Year-Old Drug Cure Alzheimer’s Disease?

https://newsblog.drexel.edu/2021/11/08/could-an-80-year-old-drug-cure-alzheimers-disease/

Could an 80-year-Old Drug Cure Alzheimer’s Disease?

by Greg Richter
Analysis of Alzheimer’s disease in hospital, conceptual image

Unlike diseases that impair the body in a myriad of physical ways, dementia can rob mental faculties and identity, as patients struggle to remember memories from previous days. As the disease progresses, victims may also forget friends or relatives and the functional skills to perform a daily routine.

The most common form of dementia, Alzheimer’s disease, is a disorder in which brain cells shrink and die. There is no cure, although some medicines, support groups and other programs may help patients manage the disease.

Considering this void, the search for better treatments presses on. More than $3 billion in National Institutes of Health funding is dedicated to Alzheimer’s research, although progress seems painfully slow for the roughly 5.8 million Americans currently suffering from the disease. Some existing drugs are controversial, such as Aduhelm, which was recently approved by the Food and Drug Administration for patients with mild cognitive impairment or early onset Alzheimer’s. Among the many questions about the drug is whether it is worth its $56,000 a year cost and side effects risk.

The glaring limitations of available therapeutics led one College of Medicine professor to consider whether the solution is not an expensive drug, but one that has been around since World War II. This is the question posited by Herbert B. Allen, MD a professor and chair emeritus in the College of Medicine, who offers a bold challenge to colleagues: consider whether penicillin could help prevent Alzheimer’s, and when combined with a disperser, whether penicillin may slow progression of the disease — or maybe even stop it altogether.

Allen’s hypothesis paper, recently published in the Journal of Alzheimer’s Disease, expands beyond penicillin’s current role in treatment of infections, like syphilis and gonorrhea, and introduces the possibility that there could be similar effectiveness when applied to Alzheimer’s.

Two regimens proposed by the hypothesis: prevention using penicillin via a once a year shot, or pills for two weeks, or treatment of early-onset Alzheimer’s using penicillin and a drug such as rifampin to break the biofilms so the penicillin can break through into the body.

Allen says the path of Alzheimer’s in the tissues of patients starts with two types of spiral-shaped bacteria, known as spirochetes, known as Borrelia burgdorferi (which also causes Lyme disease) and Treponema denticola. These dangerous bacteria enter the brain via nerve cells and brain circuits and create biofilms that are responsible for the tangles and the attack on brain cells that cause Alzheimer’s, Allen said.

“Alzheimer’s disease is a chronic infection,” said Allen. “Up until to this point in time, no one has been able to find these biofilms that cause disease hidden in live tissue.”

After reading that a colleague at the International Alzheimer Research Center in Switzerland, Judith Miklossy, MD, PhD, grew Lyme organisms from the brains of Alzheimer’s patients, Allen got an idea.

“I thought maybe there’s something to this, because Lyme is a skin disease first, so I put the same staining procedure together for tissue samples from our tissue bank here and it showed that the organisms made biofilms and the hypothesis grew from there.”

Allen explains that it’s these spiral-shaped bacteria that make the biofilms and make the beta-amyloid located inside and outside of cells and attack normal, healthy Tau protein and cause the breakdown of nerve cells.

Miklossy is credited with the discovery that the pathology of syphilis and Alzheimer’s are the same, Allen said.

Allen points to penicillin’s success in preventing syphilis and psoriasis as possible reason why it may have success in Alzheimer’s and possibly other neurodegenerative diseases. Despite this, Allen says research funding prioritizes new drug development over study of existing drugs like penicillin. Following the money to see part of the reason why, Allen points to billions of dollars in revenue for drugs like Humira, with billions of dollars in sales each year to psoriasis and rheumatoid arthritis patients.

The first data showing that spiral-shaped bacteria played a role in Alzheimer’s was discovered by Alan MacDonald, MD, back in the 1980s when MacDonald was working as a pathologist at Southhampton Hospital in New York. This latest hypothesis from Allen follows his decades of research in dermatology, including a 2014 JAMA Dermatology paper showing that eczema is also an infection.

Those over age 65 and/or with a family history of Alzheimer’s, are at greater risk of the disease. There are also specific genes implicated in Alzheimer’s risk, such as the risk gene APOE-e4. Estimates suggest that roughly 40 to 65 percent of those diagnosed with the disease have this gene. There are very rare deterministic genes in about one out of every hundred cases that guarantee an individual with the gene will develop Alzheimer’s.

_____________________
For more:

Category:

Alzheimer's, Lyme, research, Treatment, Uncategorized

Mitral Valve Dysfunction from Lyme Carditis

https://danielcameronmd.com/mitral-valve-dysfunction-lyme-carditis/

Mitral valve dysfunction from Lyme carditis

Man being examined with stethescope for mitral valve problems from Lyme carditis.

Lyme carditis is an uncommon but important manifestation of Lyme disease. In their study, Malik and colleagues describe the case of a young man with Lyme carditis with left ventricular dysfunction and valvular involvement occurring one week after a tick bite. [1]

By

The 22-year-old man was admitted to the hospital with cardiac problems. He suffered from morbid obesity and  complained of chest pain and lightheadedness for several days. During his examination, he was sweaty with a fast pulse of 115. He also reported having an erythema migrans (EM) rash.

Clinicians initially suspected the patient had non-segment elevation myocardial infarction (STEMI) and prescribed intravenous heparin, the authors explain in the case report, “Early Onset Lyme Myopericarditis With Left Ventricular Dysfunction and Mitral Regurgitation.”

“Echocardiogram was done which showed a left ventricular ejection fraction (LVEF) of 49% with mild diffuse hypokinesis, and moderate to severe mitral regurgitation,” the authors wrote.

Test results were positive for Lyme disease and the man was treated with intravenous ceftriaxone.

“If left untreated, Lyme carditis can lead to acute heart failure and sudden cardiac death thus prompt diagnosis and treatment are essential in management.”

“A repeat echocardiogram was performed, which showed an improvement of the previously visualized mitral regurgitation and normalization of LVEF,” the authors wrote.

The patient had a marked improvement in his symptoms and resolution of his rash. He was discharged home with a 3-week course of oral doxycycline.

“On a 1-month follow-up, patient remains asymptomatic and is back to his previous baseline,” according to the authors.

Cardiac manifestations in Lyme disease typically occur 1 to 2 months after the onset of infection, the authors wrote.  “In our patient, however, Lyme carditis was seen a little over 1 week after known tick exposure.”

A growing number of cardiac manifestations due to Lyme disease have been described. “Clinical manifestations of Lyme carditis include arrhythmias, conduction abnormalities, myopericarditis, ventricular dysfunction, and acute heart failure,” the authors wrote.

“Left ventricular dysfunction, as seen in our patient, has been reported to have an incidence of 0.5%.”

Valvular dysfunction due to Lyme carditis is rare. “To date, about 7 cases of valvular involvement in Lyme carditis have been reported making this phenomenon exceedingly rare.”

“If there is a high suspicion for Lyme carditis, empiric treatment with antibiotics should be started while the initial evaluation is pending.”

Death from Lyme carditis is rare. “A case series published by the CDC reported 3 individual deaths that were attributed to Lyme disease by postmortem examination indicating that lack of treatment can lead to fatalities.”

Shen and colleagues described the death of a 25-year-old man with Lyme carditis. “He presented with syncope and second-degree Mobitz type 2 heart block, as well as disseminated erythema migrans rash.”²

The patient received a temporary pacemaker and was discharged after 4 days of intravenous ceftriaxone.

“The patient returned home to a different state and reportedly died at home about 1 week after discharge.” There was no autopsy report or records to determine the cause of death.

Related Articles:

Podcast: Young man dies from Lyme carditis
Lyme carditis diagnosis: 18 cases
Patients can die when Lyme carditis is not treated

References:
  1. Malik MB, Baluch A, Adhikari S, Quraeshi S, Rao S. Early Onset Lyme Myopericarditis With Left Ventricular Dysfunction and Mitral Regurgitation. J Investig Med High Impact Case Rep. Jan-Dec 2021;9:23247096211045267. doi:10.1177/23247096211045267
  2. Shen RV, McCarthy CA, Smith RP. Lyme Carditis in Hospitalized Children and Adults, a Case Series. Open Forum Infect Dis. Jul 2021;8(7):ofab140. doi:10.1093/ofid/ofab140

__________________

For more:

Category:

Heart Issues, Lyme, research, Treatment

Tick Bite Leads to Multiple Co-infections

https://danielcameronmd.com/tick-bite-multiple-co-infections/

Tick bite leads to multiple co-infections

Man in hospital bed with co-infections from a tick bite.

In their case report “One man, three tick-borne illnesses” Grant and colleagues describe a 70-year-old man who was admitted to the emergency department with ongoing fevers, ankle edema and nausea. [1] One month earlier he noticed a small raised red lesion on his left ankle, which he believed was an insect bite.

By

“Two days after noting this ankle lesion, the patient noticed an erythematous rash on his neck and chest,” the authors explain. He was prescribed an antihistamine and 7-day course of trimethoprim–sulfamethoxazole.

The rash resolved after 5 days of antibiotic treatment, but the man continued to have pain and swelling in his ankle.  The pain spread to his left hip and he was “diagnosed with sciatica and prescribed gabapentin.”

The patient had reportedly travelled to an endemic area of the United States. And was therefore, suspected of having a tick-borne illness.

“Physicians must maintain a high level of suspicion for co-infection, as untreated disease can result in long term and sometimes life-threatening sequelae,” the authors suggest.

He tested positive for Borrelia burgdorferi, Anaplasma phagocytophilum and Babesia microti serologies.

The patient’s symptoms improved with treatment, but one year later, he continued to have symptoms of neuropathy at the site of the presumed insect bite.

References:
  1. Grant L, Mohamedy I, Loertscher L. One man, three tick-borne illnesses. BMJ Case Rep. 2021 Apr 16;14(4):e241004. doi: 10.1136/bcr-2020-241004. PMID: 33863772; PMCID: PMC8055128.

__________________

**Comment**

A perfect example of how mainstream medicine is hopelessly lost in its own hubris.

  1. Seven days of treatment of anything will not solve this
  2. trimethoprim–sulfamethoxazole, commonly known as Bactrim DS will not touch Babesia at all
  3. Bactrim DS, while a great drug, should not be the first choice for Lyme disease – and he had a clear EM rash, which is diagnostic for Lyme – no testing required
  4. It is common knowledge that the EM rash will wax and wane all on its own and should never be used to determine if treatment is working or not
  5. Doxycycline is still the best front-line drug for both Lyme and Anaplasmosis, but is far from sufficient in and of itself
  6. It is not surprising at all that this poor man continued to suffer with neuropathy, which they will undoubtedly blame on anything but tick-borne illness and it will never occur to them in a million years to treat him with numerous antimicrobials simultaneously for far longer than 7 days.  Myopia is a a very real condition

For more:

For Lyme treatment:  https://madisonarealymesupportgroup.com/2016/02/13/lyme-disease-treatment/

For Anaplasmosis treatment:  https://madisonarealymesupportgroup.com/category/anaplasmosis-treatment/

For Babesia Treatment:  https://madisonarealymesupportgroup.com/category/babesia-treatment/

Category:

Anaplasmosis, Babesia, Lyme, research